Annual Drug Patent Expirations for ESKATA Eskata is a drug marketed by Aclaris and is included in one NDA. There are six patents protecting this drug. This drug has twenty-nine…
The post New patent expiration for Aclaris drug ESKATA appeared first on D…
This chart shows the pharmaceutical companies with the most patents in Japan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug patent…
Which pharmaceutical companies have the most drug patents in Japan? Read Post »
This article was originally published by Guy Shtar, Louise Azulay, Omer Nizri, Lior Rokach & Bracha Shapira in Scientific Data volume 9, Article number: 263 under a Creative Commons Attribution…
The post CDCDB: A large and continuously updated drug com…
CDCDB: A large and continuously updated drug combination database Read Post »
This chart shows the drugs with the most patents in Russian Federation. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical drugs have the most drug patents in Russi…
Which pharmaceutical drugs have the most drug patents in Russian Federation? Read Post »
This chart shows the drugs with the most patents in Norway. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Norway? …
Which pharmaceutical drugs have the most drug patents in Norway? Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Italy? Read Post »
Annual Drug Patent Expirations for JATENZO Jatenzo is a drug marketed by Clarus and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for Clarus drug JATENZO appeared first on DrugPatentW…
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have supplementary protec…
Which drugs have supplementary protection certificates in the most countries? Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Slovakia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutica…
Which pharmaceutical companies have the most SPCs in Slovakia? Read Post »
Annual Drug Patent Expirations for MYTESI Mytesi is a drug marketed by Napo Pharms Inc and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Napo Pharms drug MYTESI appeared first on DrugPate…
New patent expiration for Napo Pharms drug MYTESI Read Post »
Get new actionable insights and updates from BiotechBlog
